you're getting a Johnny Bairstow t-shirt for the Bruns mate......

First 3 Last

Share
Profile

Follow
dunnomuch

2,237 Posts.

913

03/07/23

12:40

Post #: 68587857
Share

Originally posted by thecableguy: ↑

Shuffling chairs here or getting serious??

"Ron has been Non-Executive Chairman of HeraMED since August 2018 during which time he has assisted management in progressing the business from its developmental phase to the current phase that sees HeraMED on the cusp of broader commercialisation, particularly in the key target markets of USA and Australia."

Are we going to get extra special Ron now? Has he been holding things back since 2018 and now we get full access to his black book??

Not sure on how these games play out, but the only paragraph that I was keen on was:

"As HeraMED Executive Chairman, Ron will bring his significant experience to all aspects of the commercialisation process including manufacturing, sales and marketing, a focus on non-dilutive funding as well as revenue growth all with a view to the creation of shareholder value. "

Non dilutive funding, bring it on ASAP please Dr. Ron.

Shareholder value, yes well there would be less than 1% of holders that is above there average buy in price, this bit wont be too hard to achieve.

Hope he can deliver on both of those "views".

Regards to all, and stay in your crease...

Just another opinion.

TCG

Expand

you're getting a Johnny Bairstow t-shirt for the Bruns mate...

by the time the cricket is on in Brisbane we are either going to be saying cheers to a company on the move at the mighty Brunswick Heads pub or nursing an almighty tax loss... I'm betting on the former so you better get your leave pass sorted.

HMD Price at posting: 6.9¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

COB

Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one

OJC

SPC to merge with Original Juice Co and Nature One Dairy

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

There are more pages in this discussion • 6 more messages in this thread...

First 3 Last

Add HMD (ASX) to my watchlist

(20min delay)
Last 2.1¢		Change 0.000(0.00%)		Mkt cap ! $13.29M

Open	High	Low	Value	Volume
2.1¢	2.1¢	2.1¢	$3.255K	155K

Buyers (Bids)

No.	Vol.	Price($)
1	1765	2.1¢

Sellers (Offers)

Price($)	Vol.	No.
2.3¢	200000	1

View Market Depth

No.	Vol.	Price($)
1	1765	0.021
1	755564	0.020
1	750001	0.019
1	998971	0.018
2	1042548	0.015

Price($)	Vol.	No.
0.023	200000	1
0.024	200000	1
0.025	72222	1
0.026	102000	1
0.027	150000	1

Last trade - 13.29pm 02/10/2024 (20 minute delay)

HMD (ASX) Chart

you're getting a Johnny Bairstow t-shirt for the Bruns mate......

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one

SPC to merge with Original Juice Co and Nature One Dairy

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

you're getting a Johnny Bairstow t-shirt for the Bruns mate......

Top Stories

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one

SPC to merge with Original Juice Co and Nature One Dairy

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News